ZA200501116B - Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor - Google Patents

Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor

Info

Publication number
ZA200501116B
ZA200501116B ZA200501116A ZA200501116A ZA200501116B ZA 200501116 B ZA200501116 B ZA 200501116B ZA 200501116 A ZA200501116 A ZA 200501116A ZA 200501116 A ZA200501116 A ZA 200501116A ZA 200501116 B ZA200501116 B ZA 200501116B
Authority
ZA
South Africa
Prior art keywords
prodrugs
proton pump
pump inhibitor
benzimidazole derivatives
bioavailability
Prior art date
Application number
ZA200501116A
Other languages
English (en)
Inventor
Michael E Garst
Sachs George
Shin Jai Moo
Original Assignee
Winston Pharmaceuticals Llc
Univ California
Us Gov Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winston Pharmaceuticals Llc, Univ California, Us Gov Veterans Affairs filed Critical Winston Pharmaceuticals Llc
Publication of ZA200501116B publication Critical patent/ZA200501116B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA200501116A 2002-07-19 2005-02-08 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor ZA200501116B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19

Publications (1)

Publication Number Publication Date
ZA200501116B true ZA200501116B (en) 2006-11-29

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501116A ZA200501116B (en) 2002-07-19 2005-02-08 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor

Country Status (23)

Country Link
US (3) US6897227B2 (uk)
EP (1) EP1556371B1 (uk)
JP (1) JP4463103B2 (uk)
KR (2) KR100822981B1 (uk)
AT (1) ATE323695T1 (uk)
AU (1) AU2003259154B2 (uk)
BR (1) BR0312802A (uk)
CA (1) CA2492718C (uk)
CO (1) CO5690576A2 (uk)
DE (1) DE60304726T2 (uk)
DK (1) DK1556371T3 (uk)
ES (1) ES2263028T3 (uk)
HK (1) HK1079207A1 (uk)
IL (1) IL166371A0 (uk)
MX (1) MXPA05000657A (uk)
NO (1) NO20050801L (uk)
NZ (1) NZ538221A (uk)
PL (1) PL375255A1 (uk)
PT (1) PT1556371E (uk)
RU (1) RU2292342C2 (uk)
TW (1) TW200502231A (uk)
WO (1) WO2004009583A2 (uk)
ZA (1) ZA200501116B (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
BRPI0412590A (pt) * 2003-07-15 2006-09-19 Allergan Inc processo para preparação de pró-drogas isomericamente puras de inibidores de bomba de próton
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
US20070161679A1 (en) * 2004-02-18 2007-07-12 Allergan, Inc. Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
AU2005222574A1 (en) * 2004-03-11 2005-09-29 Allergan, Inc. Methods and compositions for the treatment of conditions related to gastric acid secretion
EP1740571B1 (en) 2004-04-28 2009-07-29 Hetero Drugs Limited A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
WO2007073301A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Benzoimidazole derivatives as prodrugs of proton pump inhibitors
WO2007081871A1 (en) * 2006-01-10 2007-07-19 Allergan, Inc. Therapeutic salt compositions of sulfonyl ester prodrugs of proton pump inhibitors and methods for their preparation
US20090111856A1 (en) * 2006-05-09 2009-04-30 Mikael Brulls Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
WO2008036201A1 (en) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20100113524A1 (en) * 2006-09-19 2010-05-06 Garst Michael E Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
EP2193518A4 (en) * 2007-10-05 2010-10-27 Lg Electronics Inc PLASMA DISPLAY DEVICE
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
EP2627178B1 (en) 2010-10-11 2018-05-02 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as crth2 antagonists
RU2589709C2 (ru) 2010-12-23 2016-07-10 Мерк Шарп Энд Домэ Корп. Хиноксалины и азахиноксалины в качестве модуляторов рецептора crth2
EP2661265B1 (en) 2010-12-23 2017-03-08 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as crth2 receptor modulators
WO2016112254A1 (en) * 2015-01-09 2016-07-14 The Regents Of The University Of California Compositions and methods for treating gastrointestinal infections
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4758597A (en) 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
PL166209B1 (pl) 1990-06-20 1995-04-28 Astra Ab Sposób wytwarzania nowych pochodnych benzimidazolu PL
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
EP0764161A1 (de) * 1994-06-10 1997-03-26 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte arylalkylthioalkylthiopyridine zur bekämpfung von helicobacter-bakterien
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
BR9912937A (pt) * 1998-08-10 2001-05-08 Partnership Of Michael E Garst Pró-drogas de inibidores de bomba de prótons
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
EP1535921A1 (en) * 1998-08-12 2005-06-01 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device
EP1334971A4 (en) * 2000-10-12 2004-05-12 Takeda Chemical Industries Ltd BENZIMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
DK1556371T3 (da) 2006-08-21
TW200502231A (en) 2005-01-16
KR100788778B1 (ko) 2007-12-27
HK1079207A1 (en) 2006-03-31
KR20050047078A (ko) 2005-05-19
BR0312802A (pt) 2005-04-19
PL375255A1 (en) 2005-11-28
CA2492718A1 (en) 2004-01-29
AU2003259154B2 (en) 2006-12-07
ES2263028T3 (es) 2006-12-01
DE60304726D1 (de) 2006-05-24
CO5690576A2 (es) 2006-10-31
NO20050801L (no) 2005-02-15
IL166371A0 (en) 2006-01-16
PT1556371E (pt) 2006-09-29
US20050143423A1 (en) 2005-06-30
EP1556371B1 (en) 2006-04-19
DE60304726T2 (de) 2007-08-09
RU2005105564A (ru) 2005-10-10
WO2004009583A2 (en) 2004-01-29
WO2004009583A3 (en) 2004-03-18
KR20070005029A (ko) 2007-01-09
ATE323695T1 (de) 2006-05-15
AU2003259154C1 (en) 2004-02-09
RU2292342C2 (ru) 2007-01-27
US6897227B2 (en) 2005-05-24
JP2005536519A (ja) 2005-12-02
US20050182101A1 (en) 2005-08-18
AU2003259154A1 (en) 2004-02-09
KR100822981B1 (ko) 2008-04-16
NZ538221A (en) 2006-11-30
EP1556371A2 (en) 2005-07-27
CA2492718C (en) 2010-12-21
JP4463103B2 (ja) 2010-05-12
MXPA05000657A (es) 2005-08-19
US20040102484A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
ZA200501116B (en) Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
CA2338311A1 (en) Prodrugs of the pyridyl methyl sulfinyl benzimidazoles
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
NO20025590D0 (no) Fenylglycin-derivater
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
SE0202463D0 (sv) Novel compounds
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
TNSN06220A1 (en) Benzimidazole derivatives
NO20062699L (no) Smelteblandingsdispergeringer
MXPA05010521A (es) Inhibidores de cinasa de amida de bifenilcarboxilica p38.
MXPA05010174A (es) Derivados de indol e indolina sustituidos.
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
EA200801200A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ
AP2000001900A0 (en) Halogeneted amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
TW200420545A (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
ATE322487T1 (de) Hydroxamsäure-derivate
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TW200733963A (en) Cough inhibitor
MXPA05009282A (es) Derivados de anilina sustituidos.
ATE460932T1 (de) Intranasale zusammensetzungen
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.